NK/T-CELL LYMPHOMA OF NASOPHARYNX (DIAGNOSIS)

Clinical trials for NK/T-CELL LYMPHOMA OF NASOPHARYNX (DIAGNOSIS) explained in plain language.

Never miss a new study

Get alerted when new NK/T-CELL LYMPHOMA OF NASOPHARYNX (DIAGNOSIS) trials appear

Sign up with your email to follow new studies for NK/T-CELL LYMPHOMA OF NASOPHARYNX (DIAGNOSIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Immunotherapy trial offers new hope for rare lymphoma patients

Disease control Ongoing

This study is testing whether the immunotherapy drug pembrolizumab can shrink early-stage NK/T-cell lymphoma in patients who haven't received chemotherapy yet. The trial involves 19 participants with this rare cancer affecting the nasal and throat areas. Researchers want to see h…

Matched conditions: NK/T-CELL LYMPHOMA OF NASOPHARYNX (DIAGNOSIS)

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

NK/T-CELL LYMPHOMA OF NASOPHARYNX (DIAGNOSIS)

Get alerted when new NK/T-CELL LYMPHOMA OF NASOPHARYNX (DIAGNOSIS) trials appear

Immunotherapy trial offers new hope for rare lymphoma patients